PMID: 6106342Jan 1, 1980Paper

Effect of a somatostatin analog on insulin requirement and hormone levels in 6 insulin-dependent juvenile-onset diabetics subjected to artificial pancreas

Acta diabetologica latina
G LentiG Pagano

Abstract

This study was performed in order to investigate the effect of a 12-h infusion of the somatostatin selective analog D-Trp8, D-Cys14 Serono, (SRIF-A), on insuli requirement and C-peptide (CP), growth hormone (GH) and glucagon (IRG) levels in 6 insulin-dependent diabetics submitted to 60-h artificial pancreas (Biostator Miles) metabolic control from 2000 of the first day to 0800 of the fourth day. Meals were given at 1200 and 1700 of the second and third day. Before meals and 1-2 h after meals, plasma levels of CP, GH and IRG were measured. The two 12-h periods (midday-midnight) with and without continuous SRIF-A 12-h infusion (40 microgram/h) were considered. The SRIF-A infusion caused a 20% reduction in insulin requirement (p < 0.05) and a slight but significant reduction of GH levels (p < 0.05). CP and IRG were unaffected.

References

Jul 1, 1979·Metabolism: Clinical and Experimental·P Raskin
Nov 1, 1978·Metabolism: Clinical and Experimental·R H Unger
Nov 1, 1978·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·V SchusdziarraR Unger
Jan 1, 1976·Annual Review of Medicine·R Guillemin, J E Gerich
May 8, 1975·The New England Journal of Medicine·J E GerichP H Forsham
Jan 24, 1977·Biochemical and Biophysical Research Communications·C MeyersF Labrie
May 1, 1977·The Journal of Clinical Endocrinology and Metabolism·W WaldhäuslE Deutsch
Jul 28, 1977·The New England Journal of Medicine·W V TamborlaneP Felig
Jan 1, 1976·Clinical Endocrinology·D SarantakisN H Grant
Nov 1, 1975·The Journal of Clinical Investigation·D S Schade, R P Eaton
Nov 1, 1980·Diabetologia·F MassaraG M Molinatti

❮ Previous
Next ❯

Citations

Mar 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·R R DaviesD G Johnston

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.